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DDX3 is a DEAD-box RNA helicase that we and others have previously implicated in anti-
viral immune signalling pathways leading to type I interferon (IFN) induction. We previ-
ously demonstrated that it directly interacts with the kinase IKKε (IκB kinase ε), enhances
it activation, and then facilitates phosphorylation of the transcription factor IRF3 by IKKε.
However, the TLR7/9 (Toll-like receptor 7/9)-mediated pathway, one of the most physiolo-
gically relevant IFN induction pathways, proceeds independently of IKKε or the related
kinase TBK1 (TANK-binding kinase 1). This pathway induces type I IFN production via the
kinases NIK (NF-κB-inducing kinase) and IKKα and is activated when plasmacytoid den-
dritic cells sense viral nucleic acids. In the present study, we demonstrate that DDX3 also
directly interacts with IKKα and enhances its autophosphorylation and -activation.
Modulation of DDX3 expression consequently affected NIK/IKKα-mediated IRF7 phos-
phorylation and induction of type I interferons. In addition, alternative NF-κB (nuclear
factor-κB) activation, another pathway regulated by NIK and IKKα, was also down-regu-
lated in DDX3 knockdown cells. This substantially broadens the effects of DDX3 in innate
immune signalling to pathways beyond TBK1/IKKε and IFN induction. Dysregulation of
these pathways is involved in disease states, and thus, our research might implicate
DDX3 as a potential target for their therapeutic manipulation.
Introduction
Several DExD/H-box RNA helicases, including DDX3, have recently been implicated to participate in
innate antiviral responses mediated by pattern recognition receptors (PRRs), either by directly acting
as receptors for viral nucleic acids or by functioning as downstream signalling intermediates [1]. Our
previous work has shown that DDX3 can act as a multifunctional adaptor molecule in the RIG-I (ret-
inoic acid-inducible gene I) signalling pathway [2–4]: it directly interacts with the kinase IKKε (IκB
kinase ε) and enhances its autophosphorylation and -activation. IKKε also directly phosphorylates
DDX3 at several serine residues in its N-terminal tail region, with phosphorylation of serine 102 being
required for the subsequent recruitment of its substrate IRF3 (interferon regulatory factor 3) into the
complex and subsequent induction of type I interferons (IFNs) [3]. Our data therefore suggested that
DDX3 acts as a signalling adaptor molecule that facilitates the co-ordinated activation of IKKε and its
substrate IRF3 [3]. Other groups have confirmed the role of DDX3 in IFN induction, but have placed
it at different levels in the signalling pathways [5–9]: it was suggested that DDX3 can directly bind to
the ifnb promoter and act as a transcriptional regulator [9], and also that DDX3 acts as a receptor for
HCV RNA and is placed upstream of MAVS (mitochondrial antiviral signalling) [7], the crucial mito-
chondrial adaptor molecule in the RIG-I pathway.
While most innate immune signalling pathways leading to type I interferon induction, including
those mediated by Toll-like receptor (TLR) 3, TLR4, the RIG-like helicases (RLHs) and cytosolic
DNA receptors, converge on IKKε/TBK1 (TANK-binding kinase 1) for phosphorylation of IRF3 and
IRF7, it was shown that TLR7 and TLR9 signalling to IFN induction is independent of these two
kinases [10,11]. TLR7 and TLR9 detect viral nucleic acids (single-stranded RNA and unmethylated
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CpG DNA, respectively) in the endosomal lumen and trigger the induction of large amounts of type I interfer-
ons, in particular IFN-α [12]. This pathway is mainly active in plasmacytoid dendritic cells due to their expres-
sion of TLR7 and TLR9 and high constitutive levels of the transcription factor IRF7. IRF7 activation in this
pathway is mediated by NIK (NF-κB-inducing kinase) and IKKα [11]. NIK facilitates IKKα activation down-
stream of Myd88 and TRAF6 (TNF receptor-associated factor 6), conferring on it the ability to phosphorylate
IRF7 and activate type I interferon promoters [13,14]. TLR7/9-mediated IFN production from plasmacytoid
dendritic cells (pDCs) is thought to be highly relevant during viral infections [15], and thus, we investigated
here whether DDX3 also contributes to this physiologically important IKKε/TBK1-independent IFN induction
pathway.
In addition, NIK and IKKα also co-operate to activate the alternative NF-κB (nuclear factor-κB) pathway,
which leads to processing of p100 to the active p52 NF-κB subunit [16]. This pathway is mainly activated
downstream of CD40 and related receptors, and has been shown to play a role in the development of secondary
lymphoid organs, bone metabolism, survival and maturation of B-cells and thymic deletion of autoimmune
T-cells. Hyperactivation of the p52 pathway has been linked to cellular transformation and the emergence of
various haematopoietic and solid tumours [17]. It has also been shown that the alternative NF-κB pathway is
activated downstream of RIG-I, where it contributes to the induction of chemokines and antiviral immune
responses [18,19].
Thus, IKKα is of major importance for these two immunorelevant signalling pathways, and we therefore
aimed to investigate whether DDX3 regulates IKKα activation in a similar manner to IKKε [3]. The data we
present here demonstrate that DDX3 can indeed directly enhance IKKα activation and that it is a positive regu-
lator of NIK–IKKα-mediated IRF7 activation and the alternative NF-κB pathway. This further broadens the
involvement of DDX3 in innate immune signalling pathways.
Experimental
Plasmids, recombinant proteins and antibodies
DDX3 and K7 expression constructs (in pCMV-myc, pCMV-Ha or pHisParallel2) have been described in our
previous studies [3,4]. IKKα-Flag and NIK-Flag were provided by Prof. Luke O’Neill (Trinity College Dublin),
and Flag-IRF7 was provided by Prof. Kate Fitzgerald (University of Massachusetts). GST
(glutathione-S-transferase)-IRF7 (aa 468–503) peptides and constructs were kindly provided by Prof. John
Hiscott and Dr Qiang Sun (McGill University, Montreal). Purified recombinant protein kinase GST-IKKα was
purchased from Millipore and recombinant GST-NIK was purchased from Proqinase (Freiburg, Germany). The
antibodies used were anti-Flag-M2 mAb (Sigma–Aldrich), anti-Myc mAb clone 9E10 (Sigma–Aldrich),
anti-HA (hemagglutinin) mAb (Covance), anti-DDX3 (Santa Cruz or Bethyl Laboratories), anti-p52/p100
(Millipore), anti-IRF7 (Santa Cruz), anti-IKKα, anti-phospho-Ser176/180-IKKα, anti-phospho-Ser 866/
870-p100, and anti-phospho-Ser471/472-IRF7 (all Cell Signaling Technology), anti-His (Sigma–Aldrich), and
anti-GST (Promega). Secondary AlexaFluor488- and AlexaFluor594-coupled antibodies were purchased from
Invivogen.
Cell culture and transfection
HEK293T and HEK293_TLR7 cells (Invivogen) were maintained in DMEM, and THP1 cells were maintained
in RPMI. Media were supplemented with Glutamax™, 10% foetal calf serum, and gentamycin. Transient DNA
transfections for immunoprecipitations and pulldowns were performed using the calcium phosphate method.
The total amount of DNA was kept constant by the addition of empty vector. Transfection for reporter gene
assays was performed in 96-well plate format using Genejuice™ with a total of 230 ng of DNA.
Short hairpin RNA knockdown of DDX3
Lentiviral particles were generated by transfecting HEK293T cells with either pTRIPZ shDDX3
(V2THS_228965, Thermo Scientific) or the corresponding non-silencing control (NSC), and the packaging
vectors pSDAX2 and pMD2 in the presence of chloroquine sulfate. Lentivirus-containing supernatants were
harvested and concentrated using PEG precipitation. HEK293, HEK293_TLR7, or THP1 cells were transduced
with shDDX3 or NSC lentivirus at an MOI of 10. Transduced cells were selected in medium containing 3 mg/
ml puromycin. For use in experiments, cells were cultured in the absence of puromycin and DDX3 knockdown
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was induced by the addition of 0.5 mg/ml doxycycline for 24–48 h. Successful knockdown of DDX3 was con-
firmed by real-time PCR and Western blot (WB) analysis.
His-pulldown assays
His-tagged DDX3 was purified from Escherichia coli BL21(DE3) cultures transformed with relevant expression
constructs using Nickel-Agarose beads. For pulldowns, equal amounts of the different His-tagged DDX3 trun-
cations were used, as estimated by SDS–PAGE and Coomassie staining prior to use. Cell lysates containing
Flag-tagged protein expressed in HEK293T cells, or 0.1 mg of GST-IKKα (Millipore) or GST-NIK (Proqinase),
were then incubated with His-tagged DDX3 immobilised on Nickel-Agarose. Protein complexes were precipi-
tated and washed thoroughly, before being subjected to SDS–PAGE and WB analysis.
Co-immunoprecipitation assays
Co-immunoprecipitation assays were performed from cell lysates of transiently transfected HEK293T or
HEK293_TLR7 cells, which were harvested 24 h after transfection. Cells were lysed in IP (immunoprecipitation)
lysis buffer (50 mM Hepes pH 7.4, 150 mM NaCl, 2 mM EDTA, 1% NP-40, 10% glycerol, 10 mM NaF, 1%
Triton X-100, 10 mM DTT, and protease inhibitors). Cell lysates were incubated with 20 ml of Flag-M2
Agarose (Sigma–Aldrich) or Protein G agarose that had been pre-coupled with relevant antibodies at 4°C over-
night and blocked with 5% bovine serum albumin. The immunoprecipitated protein complexes were washed
thoroughly and then eluted by boiling in Laemmli sample buffer, before being subjected to SDS–PAGE and
WB analysis. Endogenous co-immunoprecipitation between DDX3and IKKα was carried out from lysates of
CLO75-stimulated HEK293_TLR7, and a matched isotype control antibody was used as a control for non-
specific pulldown.
Immunofluorescent staining and confocal microscopy
HEK293 cells were seeded on sterile glass cover slips in six-well plates and transfected with expression con-
structs as indicated using the calcium phosphate method. After 24 h, they were washed, fixed with 4% parafor-
maldehyde, and permeabilised with 0.5% Triton X-100. After blocking with BSA, cells were stained with the
appropriate primary antibodies, followed by Alexa-Fluor488- or AlexaFluor594-labelled anti-species secondary
antibody (Invitrogen). After staining, cells were mounted in SlowFade Gold Antifade Reagent containing DAPI
(Invitrogen) on microscope slides and sealed using clear nail varnish. Cells were viewed using an Olympus
Fluoview Confocal Microscope, and analysed using the Olympus Fluoview FV10-ASW software. Cells in mul-
tiple different frames were examined and recorded in each of two repeat experiments. The determination of
Pearson’s correlation coefficients (PCCs) was carried out using the Fluoview software on transfected cells.
In vitro kinase assays
In vitro kinase assays were carried out with 55 ng of recombinant GST-IKKα (Proqinase). This was incubated
with purified recombinant substrates in kinase assay buffer (50 mM Hepes, pH 7.5, 5 mM glycerophosphate,
2 mM dithiothreitol, 0.1 mM Na3VO4, and 10 mM MgCl2) in the presence of 20 mM unlabelled ATP for
30 min at 30°C. Samples were analysed by SDS–PAGE and WB analysis with phospho-specific antibodies.
Alternatively, kinase assays were carried out in the presence of 10 mM unlabelled ATP and 5 mCi of
[γ32P]-ATP. Samples were then analysed by SDS–PAGE and autoradiography.
Reporter gene assays
Ifnb or Ifnα4 reporter assays were carried out in HEK293 or HEK293_TLR7 cells in 96-well plate format. Cells
were transfected with reporter constructs and expression vectors using GeneJuice (Merck/Millipore). About
60 ng of ifn promoter Firefly luciferase reporter gene construct was used in conjunction with 20 ng of a
pGL3-Renilla luciferase construct (ifnb reporter and pGL3-Renilla provided by Andrew Bowie, Trinity College
Dublin, ifna4 reporter provided by Pamela Osterlund, National Public Health Institute Finland). The total
amount of DNA transfected was kept constant at 230 ng/well by the addition of matching empty vector DNA.
Firefly and Renilla Luciferase activity was measured 24 h after transfection. Renilla Luciferase readings were
used to normalise for transfection efficiency.
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Real-time PCR analysis
RNA was isolated from stimulated and unstimulated THP1 NSC and shDDX3 cells using a Macherey Nagel
RNA isolation kit according to manufacturer’s instructions. cDNA was synthesised using iScript Reverse
Transcriptase (Bio-Rad), and cDNA concentration was then adjusted to 200 ng/ml. Real-time PCR analysis was
conducted using Evagreen® Mastermix (Metabion) according to manufacturer’s instructions, using an annealing
temperature of 57°C for IFNβ and 60°C for BAFF, HPRT, and DDX3 primers. Primer sequences are available
upon request. Relative expression levels were calculated using the ΔΔCt method with HPRT as the housekeeping
gene and unstimulated NSC cells as the reference. DDX3 knockdown of between 60 and 90% was achieved in
individual experiments.
HEK-Blue™ IFN assay
Supernatants were collected from CL075-stimulated THP1 cells and added to HEK-Blue IFNα/β sensor cells
(Invivogen) plated in 96-wps. SEAP production from the exposed reporter cells was then measured using
QUANTI-Blue™ reagent. SEAP production correlates to IFNα/β levels in the supernatant.
Data representation and statistical analysis
All data shown are representative of at least two independent repeat experiments, most are representative of
three to five repeat experiments. Luciferase reporter gene assays are representative of at least three independent
repeat experiments. Statistical analysis was carried out using a paired Student’s t-test unless indicated otherwise.
For clear representation, WBs have been cropped. Where a black box has been placed around WB panels, this
indicates that they were taken from the same original autorad exposure and can thus be compared for intensity.
Any adjustments for brightness and contrast that have been applied have been applied evenly across the whole
(boxed) panel.
Results
DDX3 interacts directly with IKKα
We first tested whether DDX3 and IKKα physically interact. Initially, we overexpressed Flag-tagged IKKα and
myc-tagged DDX3 in HEK293T cells and immunoprecipitated IKKα with a Flag antibody. DDX3 clearly
co-immunoprecipitated with Flag-IKKα, but was not pulled down by the Flag antibody in the absence of
Flag-IKKα (Figure 1a). In this experiment, we also observed that overexpression of IKKα induced a
higher-molecular-weight form of DDX3 (Figure 1a, middle panel) that likely represents a phosphorylated form
of DDX3. We next carried out a similar co-immunoprecipitation experiment with overexpressed Flag-tagged
NIK and myc-tagged DDX3 to determine whether DDX3 also interacts with NIK, the kinase that can activate
IKKα in the alternative NF-κB pathway and downstream of TLR7, 8, and 9. DDX3 clearly
co-immunoprecipitated with Flag-NIK, but was not pulled down by the Flag antibody in the absence of
Flag-NIK (Figure 1b). Endogenous IKKα also strongly co-immunoprecipitated with NIK (Figure 1b, bottom
panel), meaning that the observed interaction between DDX3 and NIK could be indirect and bridged by IKKα.
Next, we therefore conducted pulldown experiments with purified recombinant proteins. Recombinant
His-tagged DDX3 purified from E. coli was used in pulldowns with recombinant GST-tagged IKKα. In these
pulldowns, we observed direct binding of GST-IKKα to His-tagged DDX3 coupled to Ni-Agarose (Ni-Ag)
beads (Figure 1c). IKKα did not bind to empty Ni-Ag beads that were used as a control. This suggests that
DDX3 and IKKα can directly interact with each other. Similar pulldown experiments with purified GST-NIK
were inconclusive, and thus, we are unable to conclude whether DDX3 and NIK also directly interact or
whether the interaction is bridged by other proteins, such as IKKα. In addition to these
co-immunoprecipitation and pulldown experiments, we also visualised the cellular localisation of co-expressed
myc-DDX3 and Flag-IKKα/NΙK using immunofluorescent staining and confocal microscopy. DDX3 and IKKα
co-localised in the cytoplasm of transfected cells with an average PCC of 0.63. When Flag-NIK was also
co-expressed, the staining pattern or PCC did not change significantly (Supplementary Figure S1).
We next mapped the interaction between DDX3 and IKKα, using a range of His-tagged truncation mutants
of DDX3. IKKα interacted with full-length DDX3, DDX3 (aa 1–408) and DDX3 (aa 139–408), but not with
DDX3 (aa 409–662) or DDX3 (aa 172–408) (Figure 1d). This suggests that IKKα interacts with a region
between aa 139 and 172 of DDX3. Interestingly, this means that the main interaction site for IKKα in DDX3
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Figure 1. DDX3 interacts directly with IKKα following stimulation of the TLR7 pathway.
(a) HEK293T cells were transfected with expression constructs for Flag-IKKα and myc-DDX3. Cell lysates were harvested,
lysed, and subjected to IP with anti-Flag antibodies. Washed immunoprecipitates and corresponding cell lysates were analysed
by SDS–PAGE and Western blotting with the indicated antibodies to reveal co-immunoprecipitation of myc-DDX3. (b) Similar to
(a), but cells were transfected with an expression construct for Flag-NIK instead of Flag-IKKα to reveal co-immunoprecipitation
of myc-DDX3 with Flag-NIK. Samples were also probed for co-immunoprecipitation of endogenous IKKα (bottom panel).
(c) Purified recombinant His-DDX3 coupled to Nickel-Agarose (Ni-Ag) beads was incubated with recombinant GST-IKKα
(Millipore). Empty Ni-Ag beads were used as a control for non-specific binding. Beads were washed, boiled, and supernatants
were subjected to SDS–PAGE and Western blotting alongside an input sample, to show direct binding of GST-IKKα to His-DDX3.
(d) To map the DDX3–IKKα interaction, recombinant His-DDX3 truncation proteins were coupled to Ni-Ag beads and incubated
with a lysate from HEK293T cells expressing Flag-IKKα (amino acid positions of truncated DDX3 indicated in the figure). Empty
Ni-Ag beads were used as a control for non-specific binding. Beads were washed, boiled, and supernatants were subjected to
SDS–PAGE and Western blotting alongside an input sample. (e) HEK293_TLR7 cells were stimulated for the indicated time
periods with 1 mg/ml CL075 (a TLR7/8 ligand). Cell lysates were subjected to IP with an antibody against endogenous DDX3 or a
corresponding isotype control antibody, followed by SDS–PAGE and WB analysis to reveal co-immunoprecipitation of
endogenous IKKα. (f ) HEK293_TLR7 cells stably transduced with either an inducible shDDX3 or a corresponding NSC plasmid
were treated with doxycycline for 48 h to induce shRNA expression and then stimulated for the indicated time periods with the
TLR7/8 ligand CL075. Cell lysates were subjected to IP with an antibody against endogenous DDX3, followed by SDS–PAGE and
WB analysis to reveal co-immunoprecipitation of endogenous IKKα. (g) Like (f ), but using THP1 NSC and shDDX3 cells
stimulated for 1 h with CL075 for the co-immunoprecipitation. All blots in Figure 1a–e are representative of at least three
independent experiments. Blots in Figure 1f,g are representative of two independent repeat experiments.
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appears to be different from that for IKKε, which we previously determined to lie between aa 100 and 110 of
DDX3 [3].
Finally, we wanted to ascertain that endogenous DDX3 and IKKα interact following activation of a relevant
immune signalling pathway. Thus, we immunoprecipitated endogenous DDX3 from CL075-stimulated
HEK293_TLR7 cells, using a matching isotype antibody as a control for specificity. We observed
co-immunoprecipitation of endogenous IKKα 45 min after CL075 stimulation (Figure 1e), while the isotype
control antibody did not pull down any IKKα. In addition, we also carried out a similar
co-immunoprecipitation in stable HEK293_TLR7 cell lines that we engineered to express an inducible DDX3
shRNA (short hairpin RNA) construct or an NSC shRNA construct. DDX3 knockdown was induced by treat-
ing cells with doxycycline for 48 h, before stimulating cells with CL075 for different time periods, and immuno-
precipitating endogenous DDX3 from resulting cell lysates. In this experiment, we again saw endogenous IKKα
co-immunoprecipitating with DDX3 45 min after CL075 stimulation in control (NSC) cells, while no IKKα
was pulled down with the DDX3 antibody in cells depleted for DDX3 (DDX3 shRNA cells), indicating that the
observed DDX3–IKKα interaction bands in NSC cells are specific (Figure 1f). The interaction between DDX3
and IKKα was still detected 90 min after stimulation, but had disappeared at the 4 h time point (Figure 1f).
These data confirm that endogenous DDX3 and IKKα interact after physiological activation of the TLR7
pathway. Finally, we also immunoprecipitated DDX3 from CL075-stimulated THP1 cells that either expressed
an NSC shRNA or the DDX3 shRNA. As THP1s are a human monocyte/macrophage cell line, they likely
respond to the TLR7/8 ligand CL075 through TLR8. Again, we observed co-immunoprecipitation of IKKα with
DDX3 in CL075-stimulated THP1 cells, but not in unstimulated cells (Figure 1g), indicating that this function
is shared between TLR7 and TLR8. There was no pulldown of IKKα in DDX3 knockdown cells, confirming
that the interaction is specific.
DDX3 enhances IKKα activation
Seeing as we previously demonstrated that DDX3 enhances IKKε autophosphorylation [3], we next investigated
whether DDX3 has a similar effect on IKKα activation. In radioactive kinase assays with commercially obtained
GST-IKKα, we detected an IKKα autophosphorylation band that was reproducibly enhanced in the presence of
recombinant purified DDX3. The N-terminal domain (aa 1–408) of DDX3 was sufficient to mediate this effect
(Figure 2a). Phosphorylation of IKKα at serines 176 and 180 in the activation loop of the kinase is required for
and indicative of its activation. To confirm the effect of DDX3 on IKKα phosphorylation and clarify whether it
enhances IKKα phosphorylation at these relevant serine residues, we conducted kinase assays with unlabelled
ATP followed by detection of phospho-IKKα in WBs with an antibody specific for IKKα phosphorylated at
serines 176/180. IKKα phosphorylation at these residues was indeed enhanced in the presence of recombinant
DDX3 (aa 1–408) (Figure 2b). Total recombinant IKKα was also detected in this experiment with an
anti-IKKα antibody. We suspect that the total IKKα band appears thicker due to the appearance of phosphory-
lated higher-migrating forms of IKKα rather than uneven loading, as we repeated this experiment many times
with reproducible results (Figure 2b). Next, we co-expressed Flag-IKKα and either DDX3 or the vaccinia virus
(VACV) protein K7, which antagonises DDX3 [4], in HEK293T cells, lysed the cells after 24 h, and probed for
phosphorylated IKKα (Ser176/180) in WBs. As shown in Figure 2c, ectopic expression of DDX3 (aa 1–408)
strongly enhanced IKKα phosphorylation, while expression of its VACV antagonist K7 reduced levels of phos-
phorylated IKKα. This demonstrated that the effect of DDX3 on IKKα autophosphorylation also occurs in
cells. Finally, we wanted to confirm that endogenous DDX3 is involved in mediating IKKα phosphorylation fol-
lowing activation of a relevant immune signalling pathway. To this end, we used the HEK293_TLR7 cell lines
expressing DDX3 shRNA or a NSC. Knockdown of DDX3 was induced for 48 h before stimulation of the cells
with the TLR7 agonist CL075. While there was some background activation present in unstimulated cells,
CL075 enhanced IKKα/β phosphorylation from 15 min to 4 h after stimulation in NSC cells, with a peak at 1 h
post stimulation. In cells with shRNA-mediated DDX3 knockdown, IKKα/β phosphorylation was clearly
reduced, with some residual activation detectable at the 2 h and 4 h time points (Figure 2d). It should be noted
that the antibody for phospho-IKKα is unable to differentiate between phospho-IKKα and phospho-IKKβ due
to conservation of their activation loops, and thus it is possible that phosphorylation of both kinases is detected
and affected by DDX3 knockdown in this experiment. However, the fact that we see such a clear reduction
with DDX3 knockdown despite a possible contribution of IKKβ phosphorylation to the overall signal rather
supports our conclusion that DDX3 has a marked role in this pathway.
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DDX3 enhances NIK/IKKα-mediated IRF7 activation
We next hypothesised that increased IKKα activation should result in increased phosphorylation of its sub-
strates. As mentioned in the introduction, we were particularly interested in determining whether DDX3 can
regulate IFN induction pathways that are independent of IKKε/TBK1, such as TLR7-induced production of
IFNα. We therefore investigated whether DDX3 affects NIK/IKKα-mediated phosphorylation of IRF7, the
main transcription factor required for activation of IFNα promoters. IRF7 is not constitutively expressed in
cells other than pDCs and was undetectable by Western blotting in HEK293 cells. In all experiments involving
IRF7, we therefore ectopically expressed a small amount of Flag-IRF7. We first overexpressed NIK, IKKα, IRF7
and DDX3 in HEK293T cells, followed by detection of phospho-IRF7 by Western blotting (using an antibody-
specific IRF7 phosphorylated at serines 471/472, which is indicative of its activation). As expected,
co-expression of NIK and IKKα led to activatory phosphorylation of IRF7 (Figure 3a, lane 2), which was
further enhanced by DDX3 expression (Figure 3a, lane 3). To confirm that endogenous DDX3 is required for
mediating NIK/IKKα-induced IRF7 activation, we next used stable HEK293 cell lines containing the inducible
DDX3 shRNA construct or an NSC construct, as described above. We induced knockdown of DDX3 for 48 h,
followed by transfection of cells with NIK, IKKα, and IRF7 expression constructs. Phosphorylation of IRF7 was
significantly reduced in cells with DDX3 knockdown compared with control (NSC) cells (Figure 3b), confirm-
ing that DDX3 is an upstream regulator of IRF7 activation by NIK and IKKα.
Figure 2. DDX3 enhances autophosphorylation of IKKα in the activation loop.
(a,b) Kinase assays were carried out with recombinant GST-IKKα (Millipore) in the presence or absence of the N-terminus of
DDX3 (aa 1–408), demonstrating that DDX3 enhances autophosphorylation of IKKα in in vitro assays. In (a), the assay was
carried out in the presence of [γ-32P]-ATP and (auto-)phosphorylated IKKα was detected by SDS–PAGE and autoradiography,
which demonstrates incorporation of [γ-32P]-ATP. In (b), the assay was carried out in the presence of unlabelled ATP, and IKKα
phosphorylated in the activation loop (Ser176/180) was detected using a phospho-specific antibody in WB analysis. Intensity
of the phospho-IKKα bands was quantified using ImageJ in three repeat experiments and the graph depicts the average
intensities ±SD. Statistical analysis was carried out using a paired t-test. For (c), IKKα was ectopically expressed in HEK293T
cells, together with either Ha-DDX3 (1–408) or Ha-K7 (a viral antagonist of DDX3). 24 h later, cells were harvested, lysed, and
subjected to SDS–PAGE and WB analysis to detect IKKα phosphorylated at Ser 176/180, demonstrating that DDX3 also
enhances IKKα (auto-)phosphorylation in cells. Intensity of the phospho-IKKα bands was quantified using ImageJ in four repeat
experiments and the graph depicts the average intensities ±SD. Statistical analysis was carried out using a paired t-test. For
(d), HEK293_TLR7 cells stably transduced with either an inducible shRNA construct for DDX3 (shDDX3) or a corresponding
NSC plasmid were treated with doxycycline for 48 h to induce shRNA expression and then stimulated for the indicated time
periods with the TLR7/8 ligand CL075. Cells were then lysed and subjected to SDS–PAGE and Western Blotting to detect IKKα
phosphorylated at Ser176/180 and confirm knockdown of DDX3. This experiment demonstrated reduced IKKα phosphorylation
in cells with DDX3 knockdown, confirming a role for endogenous DDX3 in IKKα activation downstream of TLR7. All blots in
Figure 2 are representative of at least three independent experiments.
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Figure 3. DDX3 regulates IKKα-mediated IRF7 phosphorylation and interferon induction. Part 1 of 2
(a) HEK293T cells were transfected with expression constructs for Flag-IRF7, Flag-NIK, Flag-IKKα, and Ha-DDX3 as indicated,
and harvested and lysed for SDS–PAGE and WB analysis 24 h later. Activation of IRF7 was detected with a phospho-specific
antibody for IRF7 phosphorylated at Ser471/472, and expression of NIK, IKKα, IRF7, and DDX3 was confirmed using
epitope-tag antibodies as indicated. Ectopic expression of DDX3 enhanced NIK/IKKα-mediated IRF7 phosphorylation in this
setting. (b) HEK293 cells stably transduced with either the inducible DDX3 shRNA construct (shDDX3) or the NSC construct
were treated with doxycycline for 24 h to induce shRNA expression, before being transfected with expression constructs for
Flag-IRF7, and empty vector (EV), or expression constructs for Flag-IKKα alone or together with Flag-NIK. Cells were
harvested, lysed, and subjected to SDS–PAGE and WB analysis 24 h after transfection. Activation of IRF7 was detected with
the antibody against phospho-IRF7 (Ser471/472), and correct expression of NIK, IKKα, and IRF7 was confirmed with the
anti-Flag antibody, and knockdown of endogenous DDX3 by blotting for DDX3. We quantified band intensities across four
repeat experiments using ImageJ and normalised intensity of phospho-IRF7 to total IRF7. The level of phospho-IRF7 in NIK/
IKKα-transfected NSC cells (lane 3) was set to 100% in each individual experiment and the level of phosphor-IRF7 in NIK/
IKKα-transfected shDDX3 cells (lane 6) expressed as a percentage thereof. The graph depicts the mean percentage ± SD.
Statistical analysis was carried out using a paired Student’s t-test. Cells with DDX3 knockdown (shDDX3) had reduced levels of
phospho-IRF7 compared with control (NSC) cells, confirming that endogenous DDX3 is involved in mediating IRF7
phosphorylation downstream of NIK/IKKα. (c–e) Cells were transfected with an IFNα4 promoter Firefly luciferase reporter
construct together with a pGL3_Renilla luciferase reporter to control for transfection efficiency, and expression constructs as
indicated. The Firefly/Renilla ratio was calculated for each sample and then normalised to the unstimulated control. (c)
HEK293-TLR7 cells were transfected with reporter constructs and an expression construct for DDX3, and stimulated with
CL075 24 h after transfection for an additional 24 h. CL075-induced activation was set at 100% for each individual experiment
and all other values calculated relative to this. Data shown represent the mean values from three independent experiments
±SD. Statistical analysis was carried out using a paired t-test. (d) IFNα4 reporter assays were carried out in HEK293 cells
transfected with expression constructs for NIK, IKKα, and DDX3 as indicated. Data analysis and representation as in (c), with
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DDX3 is part of the TLR7/8 signalling pathway to IFN induction
IRF7 activation leads to induction of type I interferon promoters. We therefore investigated next whether
DDX3 overexpression or knockdown modulates IFN induction downstream of TLR7/8 stimulation and NIK/
IKKα. We first used an IFNα4 promoter luciferase construct, which is predominantly activated by IRF7 (rather
than IRF3) [20]. Stimulation of HEK293_TLR7 cells with CL075 activated the IFNα4 promoter, and this activa-
tion was further enhanced by ectopic expression of increasing amounts of DDX3 (Figure 3c). While this did
not reach statistical significance (P = 0.085, n = 3, paired t-test), there was nonetheless a trend towards enhanced
IFNα4 promoter activation in DDX3-overexpressing cells. We next expressed NIK and IKKα together in
HEK293 cells, which - as expected - also strongly activated the IFNα4 promoter. Co-expression of DDX3 sig-
nificantly enhanced IFNα4 promoter activation induced by NIK/IKKα (P = 0.034, n = 3, paired t-test), suggest-
ing that it might act downstream of or at the level of these kinases (Figure 3d). We confirmed this further by
conducting NIK/IKKα-induced IFNα4 reporter gene assays after knocking down expression of endogenous
DDX3 in our stable inducible DDX3 shRNA HEK293 cell line. When endogenous DDX3 was knocked down
in shDDX3 cells, IFNα4 promoter activation induced by NIK and IKKα was significantly reduced compared
with control (NSC) cells (P = 0.00014, n = 9, paired t-test), suggesting that DDX3 acts downstream of the NIK/
IKKα kinase complex in IFNα4 promoter activation (Figure 3e).
We next used the THP1 cell line expressing either DDX3 shRNA or the corresponding NSC construct, in
order to analyse effects of DDX3 knockdown in cells that endogenously express TLR8. Following induction of
DDX3 knockdown, THP1 cells were differentiated with PMA and then stimulated with CL075 for 24 h. Ifnb
mRNA levels were up-regulated by CL075, as detected by real-time PCR, and were significantly reduced in
DDX3 knockdown (sh) cells compared with control (NSC) cells (Figure 3f ) (P = 0.005, n = 3, paired t-test). We
also measured type I IFN and RANTES protein levels in the supernatant using the HEK-Blue™ IFNα/β
reporter cell line and RANTES ELISAs, respectively. IFN protein levels were significantly reduced in DDX3
knockdown (sh) cells compared with control (NSC) cells (Figure 3g) (P = 0.005, n = 3, paired t-test). RANTES
levels were also significantly reduced in CL075-stimulated DDX3 knockdown (shDDX3) THP1 cells compared
with control (NSC) cells. These results confirm that endogenous DDX3 is involved in the signalling pathway
leading to IFN induction downstream of TLR7/8.
DDX3 regulates p100 processing and affects expression of p52-target genes
Another immune-relevant signalling pathway that relies on the interplay between NIK and IKKα is the alterna-
tive NF-κB pathway, which leads to processing of p100 to p52 [16]. We therefore investigated whether DDX3
also regulates this separate IKKα-dependent signalling pathway. First, we expressed and stained Ha-p100 in
HEK293T cells in order to examine its subcellular localisation (both p100 and the processed p52 carry the
Ha-tag when expressed from our expression construct and will therefore be visualised by our
Figure 3. DDX3 regulates IKKα-mediated IRF7 phosphorylation and interferon induction. Part 2 of 2
NIK/IKKα-induced activation set at 100%. (e) IFNα4 reporter assays were carried out in HEK293 NSC and shDDX3 cells.
Knockdown of DDX3 was induced with doxycycline for 48 h before transfection of cells with reporter constructs and
expression constructs for NIK and IKKα. Data analysis and representation as in (d), but data represent the mean of nine
independent experiments ±SD. (f ) THP1 cells stably transduced with either the inducible DDX3 shRNA construct (shDDX3) or
the NSC construct were treated with doxycycline for 48 h to induce shRNA expression, differentiated with PMA, and then
stimulated with TLR7/8 agonist CL075 for 6 h. ifnb mRNA expression was measured using quantitative real-time PCR and is
displayed as fold induction over unstimulated control (NSC) cells. Displayed is an average of three experiments ±SD. Statistical
analysis was carried out using a paired t-test, with P-values indicated in the diagram. (g) Supernatants from experiments with
CL075-stimulated THP1 cells from (f ) were analysed for type I IFN protein production using HEK-Blue™ IFNα/β sensor cells,
based on IFNAR-induced activation of an SEAP reporter. Data are displayed as fold induction over unstimulated control (NSC)
cells and as an average of three experiments ±SD. Statistical analysis was carried out using a paired t-test, with P-values
indicated in the diagram. (h) THP1 NSC or shDDX3 cells were treated with doxycycline for 48 h to induce shRNA expression
and then stimulated with CL075 for 20 h. RANTES cytokine levels were measured with a commercially available ELISA kit
(R&D). The graph depicts the average cytokine levels from four independent experiments ±SD. Statistical analysis was carried
out using a paired t-test, with P-value indicated in the diagram.
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immunofluorescent staining approach). Co-expression of NIK/IKKα with Ha-p100 increased the nuclear local-
isation of p100/p52 as expected (due to processing of p100 to p52, which can then translocate into the
nucleus). Additional co-expression of DDX3 led to a further increase in nuclear p52, suggesting that DDX3 can
promote p100 processing to p52 (Figure 4a). Next, we used WB analysis to confirm that DDX3 affects p100
processing. We induced knockdown of DDX3 in our stably transduced HEK293 DDX3 shRNA (or NSC) cells
by treating them with doxycycline for 48 h, and then ectopically expressed NIK and IKKα, before harvesting
cells for WB analysis. NIK and IKKα co-expression clearly induced p100 phosphorylation and subsequent deg-
radation to p52 in control (NSC) cells (Figure 4b, lane 3), while p100 phosphorylation was greatly reduced and
p52 levels were lower in DDX3 knockdown (shDDX3) cells (Figure 4b, compare lane 3 and lane 6 and see
quantification graphs). We then proceeded to show that DDX3 knockdown affects downstream gene expression
mediated by p52 and chose the well-established p52-target gene BAFF (B-cell activation factor) as our read-out
[16]. We again used the THP1 cell lines stably transduced with either the DDX3 shRNA plasmid or an NSC
Figure 4. DDX3 regulates p100 processing and expression of a p52-target gene.
(a) HEK293 cells were cotransfected with expression constructs for Ha-p100, Flag-IKKα, Flag-NIK, and myc-DDX3 as
indicated. p100 and processed p52 were detected with an antibody against the Ha-tag and DDX3 was detected with an
antibody against the myc-tag, as well as species-specific secondary antibodies (AlexaFluor488/green for DDX3 and
AlexaFluor594/red for p100/p52). For quantifying nuclear localisation of p52, 30 transfected cells were selected for each
condition and the PCC between AlexaFluor594 (p100/p52) and the DAPI nuclear stain was. The graph shows the mean PCC ±
SD for each condition. Statistical analysis was carried out using an unpaired Student’s t-test (**P≤ 0.01). (b) HEK293 cells
stably transduced with either the inducible DDX3 shRNA construct (shDDX3) or the NSC construct were treated with
doxycycline for 24 h to induce shRNA expression, before being transfected with empty vector (EV), or expression constructs
for Flag-IKKα alone or together with Flag-NIK. Cells were harvested, lysed, and subjected to SDS–PAGE and WB analysis 24 h
after transfection. WBs were probed with a phospho-specific antibody for p100 phosphorylated at Ser866/870 (the
phosphorylation event that precedes degradation), an antibody that detects both p100 and the processed p52 (second and
third panel), a DDX3 antibody to confirm knockdown, a tubulin antibody to confirm equal loading, and a Flag antibody to
confirm expression of both Flag-IKKα and Flag-NIK. We quantified band intensities across two repeat experiments using
ImageJ and normalised intensity of phospho-p100 (left graph) or p52 bands (right graph) to total p100 bands. The level of
phospho-p100 or p52 in NIK/IKKα-transfected NSC cells (lane 3) was set to 100% in each individual experiment and the level
of phospho-p100 or p52 in NIK/IKKα-transfected shDDX3 cells (lane 6) expressed as a percentage thereof. The graphs depict
the mean percentage ± SD. Phosphorylation of p100 and p100 processing to p52 were reduced in DDX3 knockdown cells
(shDDX3) compared with control cells (NSC). Blots shown are representative of two independent repeat experiments. (c) THP1
cells stably transduced with either the inducible DDX3 shRNA construct (shDDX3) or the NSC construct were treated with
doxycycline for 48 h to induce shRNA expression, differentiated with PMA, and then stimulated with TLR7/8 agonist CL075 for
the indicated time periods. BAFF mRNA expression was measured using quantitative real-time PCR and is displayed as fold
induction over unstimulated control (NSC) cells. Displayed is an average of three experiments ± SD. Statistical analysis was
carried out using a paired t-test, with P-values indicated in the diagram.
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plasmid, and induced knockdown by treating cells for 48 h with doxycycline. We then differentiated THP1
cells with PMA for 24 h before stimulation with CL075. We observed up-regulation of BAFF mRNA expression
(measured by real-time PCR) at 8 or 24 h in NSC cells, which was reduced in DDX3 knockdown (shDDX3)
cells (Figure 4c), reaching statistical significance for the 24 h time point (P = 0.015, n = 3, paired t-test). This
data demonstrate that DDX3 is also involved in mediating alternative NF-κB activation downstream of NIK/
IKKα in the TLR7/8 pathway and thus broadens the downstream effects of DDX3 modulation beyond
IFN-inducing pathways.
Discussion
Our study demonstrates that DDX3 directly interacts with IKKα and enhances its kinase activity, thereby regu-
lating the activity of IKKα-dependent downstream signalling pathways. We had previously shown that DDX3
interacts with IKKε and facilitates its autophosphorylation and auto-activation [3]. According to our new data,
DDX3 exerts a similar effect on the related kinase IKKα and can thereby contribute to additional IKKε/
TBK1-independent innate immune signalling pathways. A very interesting study published while this project
was ongoing also demonstrated the DDX3–IKKα interaction, in that case occurring during HCV infection or
transfection of poly(I:C) [21]. The study showed that DDX3 co-localised with the HCV 30UTR RNA and
IKKα. Interestingly, the DDX3–IKKα interaction in this paper was suggested to result from direct recognition
of HCV RNA by DDX3 [21], thus indicating that DDX3 acts as a viral sensor in this context. This is in line
with a study published by Oshiumi et al. [7], which suggested that DDX3 recognises HCV RNA and then
signals via RIG-I/MDA5/MAVS to IFN induction. However, our previous studies have characterised DDX3 as a
downstream signalling adaptor linking IKKε and the transcription factor IRF3 [3,4], which is also supported
by several other studies [5,6,8,9]. In this present study, we observed the DDX3–IKKα interaction in the absence
of viral RNA, namely following stimulation of the TLR7/8 pathway with the synthetic ligand CL075, a thiazolo-
quinolone derivative. Knockdown of DDX3 also affected signals downstream of NIK/IKKα, suggesting that
DDX3 is able to exert an equivalent role as a signalling adaptor also in NIK/IKKα-dependent pathways. Li
et al.’s paper [21] demonstrated that IKKα was required for SREBP-mediated lipogenesis and lipid droplet for-
mation in HCV-infected Hu7.5.1 cells. As lipid droplets are crucial for efficient HCV replication and assembly,
IKKα knockdown strongly suppressed HCV replication in these cells. DDX3 is also required for HCV replica-
tion [22,23] and it is therefore conceivable that enhancement of IKKα signalling contributes to DDX3’s proviral
role in HCV replication. Our study complements this work by demonstrating that the interaction between
DDX3 and IKKα is direct and promotes IKKα autophosphorylation and -activation, resulting in enhanced
phosphorylation of IKKα’s downstream targets. While Li et al. [21] focussed on SREBP expression mediated by
CBP, we demonstrate that IRF7 activation and p100 phosphorylation and processing are also affected by
DDX3’s regulation of IKKα. Our work therefore suggests that the DDX3–IKKα link might be a double-edged
sword for the virus. On the one hand, it promotes lipid droplet formation, which favours the virus [21], but on
the other hand it promotes production of interferons and pro-inflammatory cytokines (this study). In this
context, it is very interesting that, in a follow-up study to their original work, the Liang laboratory showed that
the DDX3–IKKα interaction appears to be dynamically regulated during HCV infection, with it only occurring
early during infection. When viral protein production was high, DDX3 clustered with the HCV core protein on
lipid droplets instead [24].
Our work shows that IKKα is another kinase whose activity can be regulated directly by DDX3, similar to
IKKε [3] and CK1ε (casein kinase 1ε) [25]. These studies suggest that DDX3 employs similar mechanisms to
facilitate activation of different kinases and mediate phosphorylation of their downstream targets. Interestingly
though, the C-terminal region of DDX3 was required and sufficient for CK1 activation [25], whereas the
N-terminus was required and sufficient for IKKε and IKKα activation. We showed here that, despite the
relatedness of the IKKs, IKKα interacts with DDX3 in a slightly different manner compared with IKKε. While
IKKε binds to N-terminal and C-terminal regions of DDX3 (aa 1–110 and 409–662), but not to DDX3 (aa
139–408) [3], IKKα still binds to DDX3 (aa 139–408) but fails to bind to the C-terminus of DDX3 (aa 409–
662).
Importantly, the finding that DDX3 can directly regulate IKKα greatly broadens the downstream effects of
DDX3 manipulation on innate immune responses: (1) it affects TBK1/IKKε-independent induction of type I
interferons downstream of TLR7/8 (and most probably TLR9 given the similarity of the two signalling path-
ways) and (2. it affects IKKα-mediated signalling pathways that are independent of IRF3/7, such as the alterna-
tive NF-κB pathway, and thereby regulates expression of additional sets of genes beyond type I interferons.
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These findings, in combination with the work published by the Liang laboratory [21,24] that showed an effect
on the CBP-SREBP pathway, suggest that DDX3 generally affects downstream signalling pathways emanating
from IKKα. It is not unlikely that additional downstream pathways, such as the conventional NF-κB pathway,
could also be affected by DDX3’s regulation of IKKα [26].
Its relevance for physiological processes regulated by these pathways is worth investigating in future studies.
For example, by affecting the alternative NF-κB pathway, DDX3 could be involved in CD40 signalling, develop-
ment of secondary lymphoid organs, and B-cell survival and maturation of B-cells [17]. While it remains to be
confirmed that our finding of DDX3 regulating TLR7-mediated IFN induction extends to pDCs, the physiolo-
gically relevant cell type for this signalling pathway, this could potentially indicate a link between DDX3 and
systemic lupus erythematosus (SLE). TLR7 signalling is strongly linked SLE pathogenesis, with TLR7 activation
being triggered by anti-RNP immune complexes, resulting in the production of large amounts of type I IFN
from pDCs [27–29]. SLE is an autoimmune condition with a much higher prevalence in women compared
with men, and interestingly, DDX3(X) escapes X-inactivation [30] and might indeed be expressed to higher
levels in females compared with males [31–33]. Furthermore, there is also some evidence that the TLR7
pathway is more active in females compared with males [34,35]. Based on our data demonstrating the involve-
ment of DDX3 in TLR7 signalling, higher expression of DDX3 in females could conceivably contribute to
increased TLR7 pathway activity and thereby to the increased female prevalence of SLE.
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